Department of Molecular Pharmacology and Physiology, Morsani College of Medicine, University of South Florida, Tampa, Florida, USA.
Department of Biomedicine, Aarhus University, Aarhus, Denmark.
Acta Physiol (Oxf). 2022 Feb;234(2):e13756. doi: 10.1111/apha.13756. Epub 2022 Jan 11.
The kidneys play a major role in maintaining P homeostasis. Patients in later stages of CKD develop hyperphosphatemia. One novel treatment option is tenapanor, an intestinal-specific NHE3 inhibitor. To gain mechanistic insight into the role of intestinal NHE3 in P homeostasis, we studied tamoxifen-inducible intestinal epithelial cell-specific NHE3 knockout (NHE3 ) mice.
Mice underwent dietary P challenges, and hormones as well as urinary/plasma P were determined. Intestinal P uptake studies were conducted in vivo to compare the effects of tenapanor and NHE3 . Ex vivo P transport was measured in everted gut sacs and brush border membrane vesicles. Intestinal and renal protein expression of P transporters were determined.
On the control diet, NHE3 mice had similar P homeostasis, but a ~25% reduction in FGF23 compared with control mice. Everted gut sacs and brush border membrane vesicles showed enhanced P uptake associated with increased Npt2b expression in NHE3 mice. Acute oral P loading resulted in higher plasma P in NHE3 mice. Tenapanor inhibited intestinal P uptake acutely but then led to hyper-absorption at later time points compared to vehicle. In response to high dietary P , plasma P and FGF23 increased to higher levels in NHE3 mice which was associated with greater Npt2b expression. Reduced renal Npt2c and a trend for reduced Npt2a expression were unable to correct for higher plasma P .
Intestinal NHE3 has a significant contribution to P homeostasis. In contrast to effects described for tenapanor on P homeostasis, NHE3 mice show enhanced, rather than reduced, intestinal P uptake.
肾脏在维持磷稳态中起着重要作用。CKD 晚期患者会发生高磷血症。一种新的治疗选择是 Tenapanor,一种肠道特异性 NHE3 抑制剂。为了深入了解肠道 NHE3 在磷稳态中的作用机制,我们研究了他莫昔芬诱导的肠道上皮细胞特异性 NHE3 敲除(NHE3 -/- )小鼠。
小鼠接受饮食磷挑战,测定激素以及尿/血浆磷。在体内进行肠道磷摄取研究,以比较 Tenapanor 和 NHE3 的作用。在翻转肠囊和刷状缘膜囊泡中进行体外磷转运测量。测定肠道和肾脏磷转运蛋白的表达。
在对照饮食下,NHE3 -/- 小鼠具有相似的磷稳态,但与对照小鼠相比,FGF23 降低约 25%。翻转肠囊和刷状缘膜囊泡显示磷摄取增加,与 NHE3 -/- 小鼠中 Npt2b 表达增加相关。急性口服磷负荷导致 NHE3 -/- 小鼠的血浆磷水平升高。与载体相比,Tenapanor 急性抑制肠道磷摄取,但随后在稍后时间点导致过度吸收。在高膳食磷的情况下,NHE3 -/- 小鼠的血浆磷和 FGF23 增加到更高水平,这与 Npt2b 表达增加有关。肾脏 Npt2c 表达减少,Npt2a 表达减少趋势,但不能纠正更高的血浆磷。
肠道 NHE3 对磷稳态有重要贡献。与描述的 Tenapanor 对磷稳态的作用相反,NHE3 -/- 小鼠显示出增强而不是减少的肠道磷摄取。